首页 › 基金 › Rhenman & Partners Asset Management AB › PRCT

Rhenman & Partners Asset Management AB 对 PRCT 的持仓历史

PROCEPT BIOROBOTICS CORP · 医疗保健

Rhenman & Partners Asset Management AB 在 Q3 2026 的 13F 申报中披露持有 PRCT(PROCEPT BIOROBOTICS CORP)535,000 股,市值约 US$9.7M,约占其申报组合的 1.08%,在其申报持仓中市值排名第 39 位。 Rhenman & Partners Asset Management AB 最近 13 个申报季度中有 13 个季度披露了 PRCT 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)535.00K 股
申报持仓市值$9.75M
组合权重1.08%
首次申报Q3 2023
最近变动增持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Rhenman & Partners Asset Management AB 对 PRCT 的持仓演变

Rhenman & Partners Asset Management AB 于 Q3 2023 首次披露 PRCT 持仓:493,000 股(约 US$16.2M)。 该持仓在 Q3 2024 达到峰值 445,000 股,市值约 US$35.7M。 在 13 次申报中,Rhenman & Partners Asset Management AB 6 次增持、6 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 535,000 股、市值约 US$9.7M,环比增持 190,000 股。。 持仓曾出现大幅变动:Q1 2024 增持约 57% (随后一个季度股价上涨 24%)、Q2 2025 减持约 58% (随后一个季度股价下跌 38%)、Q3 2025 增持约 105% (随后一个季度股价下跌 12%)。

逐季持仓明细

季度股数金额变化
Q3 2023 493.00K $16.18M 新进
Q4 2023 310.00K $12.99M 减持
Q1 2024 487.06K $24.07M 增持
Q2 2024 440.00K $26.88M 减持
Q3 2024 445.00K $35.65M 增持
Q4 2024 420.35K $33.85M 减持
Q1 2025 448.00K $26.10M 增持
Q2 2025 190.00K $10.94M 减持
Q3 2025 390.00K $13.92M 增持
Q4 2025 611.00K $19.22M 增持
Q1 2026 475.00K $11.88M 减持
Q2 2026 345.00K $7.79M 减持
Q3 2026 535.00K $9.75M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PRCT 与 13F 数据

PRCT(PROCEPT BIOROBOTICS CORP)属于医疗保健行业。我们追踪的基金中还有 17 只申报持有 PRCT,申报仓位最大的包括:Soleus Capital Management, L.P. (US$22.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PRCT 的基金

查看 PRCT 的全部基金持有人 →

常见问题

How long has Rhenman & Partners Asset Management AB held PRCT?

Rhenman & Partners Asset Management AB has disclosed PRCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rhenman & Partners Asset Management AB's current position in PRCT?

As of Q3 2026, Rhenman & Partners Asset Management AB holds 535.00K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $9.75M, representing 1.08% of its reported portfolio and ranking #39.

Has Rhenman & Partners Asset Management AB been buying or selling PRCT?

In the latest 13F filing (Q3 2026), Rhenman & Partners Asset Management AB increased its position in PRCT. The position peaked in Q3 2024 at 445.00K shares.

Which other funds hold PRCT?

Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.